Eden Research product granted temporary approval in Greece.


Sustainable biopesticide developer Eden Research announced on Monday that its Cedroz product has been granted temporary approval in Greece for the 2024 growing season.

  • Eden Research
  • 02 September 2024 12:10:46
Eden Research

Source: Sharecast

The AIM-traded firm said the approval, in accordance with EU Regulation 1107/2009, allowed Cedroz to be used on potatoes to combat wireworms.

Cedroz, distributed in Greece by Eastman Chemical - Eden's commercial partner in several countries - would provide farmers with a new tool to protect potato crops from wireworms.

The pests, which are the larvae of click beetles, cause significant damage to potatoes by creating holes and tunnels, leading to reduced crop quality and yield.

Eden said the increasing prevalence of wireworms had left farmers with limited options, most of which rely on synthetic insecticides.

With an estimated 5,000 to 6,000 hectares of potato fields in Greece affected by wireworms, it said Cedroz presented a substantial commercial opportunity beyond its established role as a nematicide in horticultural crops.

“The granting of this temporary approval indicates that there are no other commercially available, viable alternatives to Cedroz for this particular use,” said chief executive officer Sean Smith.

“We have seen in previous trials, and even under a previously granted temporary approval in Italy on wireworms, that the product works well and, as such, we are confident that there is a strong business case for this use.”

At 1147 BST, shares in Eden Research were up 6.1% at 4.35p.

Reporting by Josh White for Sharecast.com.


N/A

ISIN: N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.